nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—Pargyline—MAOB—Parkinson's disease	0.00764	0.105	CrCbGaD
Tolazoline—ADRA2A—peripheral nervous system—Parkinson's disease	0.00679	0.0888	CbGeAlD
Tolazoline—Dextroamphetamine—SLC18A2—Parkinson's disease	0.00574	0.0787	CrCbGaD
Tolazoline—L-Phenylalanine—TH—Parkinson's disease	0.00542	0.0743	CrCbGaD
Tolazoline—Pargyline—MAOA—Parkinson's disease	0.00536	0.0735	CrCbGaD
Tolazoline—ADRA1A—hindbrain—Parkinson's disease	0.00521	0.0682	CbGeAlD
Tolazoline—HRH2—cardiovascular system—Parkinson's disease	0.00497	0.065	CbGeAlD
Tolazoline—Amphetamine—SLC18A2—Parkinson's disease	0.00462	0.0634	CrCbGaD
Tolazoline—Methamphetamine—SLC18A2—Parkinson's disease	0.00429	0.0588	CrCbGaD
Tolazoline—Phentermine—MAOB—Parkinson's disease	0.00413	0.0566	CrCbGaD
Tolazoline—HRH2—head—Parkinson's disease	0.00337	0.044	CbGeAlD
Tolazoline—Phenelzine—MAOB—Parkinson's disease	0.00336	0.0461	CrCbGaD
Tolazoline—HRH2—nervous system—Parkinson's disease	0.00319	0.0418	CbGeAlD
Tolazoline—Amphetamine—MAOB—Parkinson's disease	0.00317	0.0435	CrCbGaD
Tolazoline—HRH2—central nervous system—Parkinson's disease	0.00307	0.0402	CbGeAlD
Tolazoline—ADRA1A—brainstem—Parkinson's disease	0.00299	0.0391	CbGeAlD
Tolazoline—Methamphetamine—MAOB—Parkinson's disease	0.00294	0.0403	CrCbGaD
Tolazoline—Phentermine—MAOA—Parkinson's disease	0.00289	0.0397	CrCbGaD
Tolazoline—ADRA1A—forebrain—Parkinson's disease	0.00288	0.0377	CbGeAlD
Tolazoline—Phentermine—SLC6A3—Parkinson's disease	0.00249	0.0342	CrCbGaD
Tolazoline—HRH2—brain—Parkinson's disease	0.00244	0.0319	CbGeAlD
Tolazoline—ADRA1A—cardiovascular system—Parkinson's disease	0.00244	0.0319	CbGeAlD
Tolazoline—Dextroamphetamine—SLC6A3—Parkinson's disease	0.00238	0.0326	CrCbGaD
Tolazoline—Phenelzine—MAOA—Parkinson's disease	0.00236	0.0323	CrCbGaD
Tolazoline—HRH1—forebrain—Parkinson's disease	0.00223	0.0292	CbGeAlD
Tolazoline—ADRA2A—forebrain—Parkinson's disease	0.00219	0.0287	CbGeAlD
Tolazoline—Methamphetamine—MAOA—Parkinson's disease	0.00206	0.0283	CrCbGaD
Tolazoline—ADRA2C—medulla oblongata—Parkinson's disease	0.00198	0.026	CbGeAlD
Tolazoline—Amphetamine—SLC6A3—Parkinson's disease	0.00192	0.0263	CrCbGaD
Tolazoline—ADRA2C—midbrain—Parkinson's disease	0.00181	0.0237	CbGeAlD
Tolazoline—Methamphetamine—SLC6A3—Parkinson's disease	0.00178	0.0244	CrCbGaD
Tolazoline—ADRA2C—spinal cord—Parkinson's disease	0.00177	0.0232	CbGeAlD
Tolazoline—Benzyl alcohol—CYP2E1—Parkinson's disease	0.00172	0.0236	CrCbGaD
Tolazoline—ADRA1A—head—Parkinson's disease	0.00165	0.0216	CbGeAlD
Tolazoline—ADRA2A—medulla oblongata—Parkinson's disease	0.00158	0.0207	CbGeAlD
Tolazoline—ADRA2C—head—Parkinson's disease	0.00157	0.0206	CbGeAlD
Tolazoline—ADRA1A—nervous system—Parkinson's disease	0.00157	0.0205	CbGeAlD
Tolazoline—ADRA1A—central nervous system—Parkinson's disease	0.00151	0.0197	CbGeAlD
Tolazoline—ADRA2C—nervous system—Parkinson's disease	0.00149	0.0195	CbGeAlD
Tolazoline—ADRA1A—cerebellum—Parkinson's disease	0.00147	0.0193	CbGeAlD
Tolazoline—Phenelzine—CYP2E1—Parkinson's disease	0.00146	0.02	CrCbGaD
Tolazoline—ADRA2A—midbrain—Parkinson's disease	0.00145	0.0189	CbGeAlD
Tolazoline—ADRA2C—central nervous system—Parkinson's disease	0.00144	0.0188	CbGeAlD
Tolazoline—Amphetamine—DRD2—Parkinson's disease	0.00143	0.0196	CrCbGaD
Tolazoline—ADRA2A—spinal cord—Parkinson's disease	0.00141	0.0185	CbGeAlD
Tolazoline—ADRA2C—cerebellum—Parkinson's disease	0.0014	0.0184	CbGeAlD
Tolazoline—Phentermine—CYP2D6—Parkinson's disease	0.00131	0.018	CrCbGaD
Tolazoline—HRH1—head—Parkinson's disease	0.00128	0.0167	CbGeAlD
Tolazoline—Benzyl alcohol—CYP2D6—Parkinson's disease	0.00126	0.0173	CrCbGaD
Tolazoline—ADRA2A—head—Parkinson's disease	0.00126	0.0164	CbGeAlD
Tolazoline—Dextroamphetamine—CYP2D6—Parkinson's disease	0.00125	0.0172	CrCbGaD
Tolazoline—HRH1—nervous system—Parkinson's disease	0.00121	0.0159	CbGeAlD
Tolazoline—ADRA1A—brain—Parkinson's disease	0.0012	0.0157	CbGeAlD
Tolazoline—ADRA2A—nervous system—Parkinson's disease	0.00119	0.0156	CbGeAlD
Tolazoline—HRH1—central nervous system—Parkinson's disease	0.00117	0.0153	CbGeAlD
Tolazoline—ADRA2A—central nervous system—Parkinson's disease	0.00115	0.015	CbGeAlD
Tolazoline—ADRA2C—brain—Parkinson's disease	0.00114	0.0149	CbGeAlD
Tolazoline—ADRA2A—cerebellum—Parkinson's disease	0.00112	0.0147	CbGeAlD
Tolazoline—Amphetamine—CYP2D6—Parkinson's disease	0.00101	0.0138	CrCbGaD
Tolazoline—Methamphetamine—CYP2D6—Parkinson's disease	0.000934	0.0128	CrCbGaD
Tolazoline—HRH1—brain—Parkinson's disease	0.000926	0.0121	CbGeAlD
Tolazoline—ADRA2A—brain—Parkinson's disease	0.00091	0.0119	CbGeAlD
Tolazoline—ADRA1A—GPCR downstream signaling—DRD1—Parkinson's disease	0.000316	0.000371	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PLA2G6—Parkinson's disease	0.000315	0.00037	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PDYN—Parkinson's disease	0.000313	0.000368	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—MAOB—Parkinson's disease	0.000312	0.000366	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000312	0.000366	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—HTR7—Parkinson's disease	0.000309	0.000363	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—DRD2—Parkinson's disease	0.000309	0.000363	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—HTR7—Parkinson's disease	0.000308	0.000361	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—DRD2—Parkinson's disease	0.000308	0.000361	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—DRD3—Parkinson's disease	0.000306	0.000359	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GRK5—Parkinson's disease	0.000305	0.000359	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000304	0.000357	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000303	0.000356	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—DDC—Parkinson's disease	0.000301	0.000354	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GRM4—Parkinson's disease	0.000301	0.000353	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—TAC1—Parkinson's disease	0.000299	0.000352	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	0.000298	0.00035	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000297	0.000349	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000297	0.000349	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GRM4—Parkinson's disease	0.000295	0.000347	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GFAP—Parkinson's disease	0.000294	0.000346	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—DRD1—Parkinson's disease	0.000293	0.000345	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PDYN—Parkinson's disease	0.000292	0.000344	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—TAC1—Parkinson's disease	0.000292	0.000344	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	0.000292	0.000343	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GRM5—Parkinson's disease	0.000291	0.000342	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000291	0.000342	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—DRD2—Parkinson's disease	0.000287	0.000338	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—HTR7—Parkinson's disease	0.000287	0.000338	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—DRD1—Parkinson's disease	0.000287	0.000337	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000286	0.000336	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PENK—Parkinson's disease	0.000285	0.000335	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MAG—Parkinson's disease	0.000285	0.000335	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—DRD3—Parkinson's disease	0.000284	0.000334	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GSTA4—Parkinson's disease	0.000284	0.000334	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	0.000283	0.000333	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000282	0.000331	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000282	0.000331	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PENK—Parkinson's disease	0.00028	0.000329	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MAG—Parkinson's disease	0.00028	0.000329	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—DRD3—Parkinson's disease	0.000278	0.000326	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—HTR7—Parkinson's disease	0.000277	0.000325	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—DRD2—Parkinson's disease	0.000277	0.000325	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000276	0.000324	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GFAP—Parkinson's disease	0.000275	0.000323	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GRM4—Parkinson's disease	0.000274	0.000322	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GRM5—Parkinson's disease	0.000272	0.00032	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—TAC1—Parkinson's disease	0.000272	0.000319	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—EDN1—Parkinson's disease	0.000271	0.000319	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—DRD1—Parkinson's disease	0.000266	0.000313	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000265	0.000312	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000264	0.000311	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PDYN—Parkinson's disease	0.000261	0.000306	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MAG—Parkinson's disease	0.00026	0.000305	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PENK—Parkinson's disease	0.00026	0.000305	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000259	0.000305	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IGF2—Parkinson's disease	0.000259	0.000304	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—DRD3—Parkinson's disease	0.000258	0.000303	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—DRD2—Parkinson's disease	0.000257	0.000302	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—HTR7—Parkinson's disease	0.000257	0.000302	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	0.000256	0.000301	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	0.000256	0.000301	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PLA2G6—Parkinson's disease	0.000256	0.000301	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	0.000256	0.000301	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—FGF20—Parkinson's disease	0.000255	0.0003	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—EDN1—Parkinson's disease	0.000253	0.000298	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—MAOB—Parkinson's disease	0.000253	0.000298	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	0.000251	0.000295	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	0.000251	0.000295	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IGF1R—Parkinson's disease	0.00025	0.000294	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ADORA2A—Parkinson's disease	0.000247	0.000291	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—EDN1—Parkinson's disease	0.000247	0.000291	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—EDN1—Parkinson's disease	0.000246	0.000289	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GFAP—Parkinson's disease	0.000245	0.000288	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GRM5—Parkinson's disease	0.000242	0.000285	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000241	0.000283	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	0.00024	0.000283	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—FGF20—Parkinson's disease	0.000238	0.00028	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	0.000238	0.000279	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PDYN—Parkinson's disease	0.000238	0.000279	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000237	0.000279	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—HTR7—Parkinson's disease	0.000233	0.000274	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—DRD2—Parkinson's disease	0.000233	0.000274	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CYP2D6—Parkinson's disease	0.000232	0.000272	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ADORA2A—Parkinson's disease	0.000231	0.000272	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—EDN1—Parkinson's disease	0.00023	0.00027	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—INSR—Parkinson's disease	0.000228	0.000269	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CTGF—Parkinson's disease	0.000227	0.000267	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—NGF—Parkinson's disease	0.000227	0.000267	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000226	0.000265	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GFAP—Parkinson's disease	0.000223	0.000263	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000222	0.00026	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000221	0.00026	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GRM5—Parkinson's disease	0.000221	0.00026	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—HTR2A—Parkinson's disease	0.000216	0.000254	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—FGB—Parkinson's disease	0.000216	0.000254	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000215	0.000253	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000215	0.000253	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HTR1A—Parkinson's disease	0.000215	0.000252	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—INSR—Parkinson's disease	0.000213	0.000251	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FGF20—Parkinson's disease	0.000212	0.00025	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CYP2E1—Parkinson's disease	0.000212	0.000249	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TAC1—Parkinson's disease	0.000211	0.000249	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000211	0.000248	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—NQO1—Parkinson's disease	0.00021	0.000246	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	0.000208	0.000245	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—DRD1—Parkinson's disease	0.000207	0.000244	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—TH—Parkinson's disease	0.000207	0.000243	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000206	0.000242	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000206	0.000242	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	0.000205	0.000241	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000202	0.000238	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—FGB—Parkinson's disease	0.000202	0.000237	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—HTR2A—Parkinson's disease	0.000201	0.000237	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—APOE—Parkinson's disease	0.000201	0.000236	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	0.000201	0.000236	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—DRD3—Parkinson's disease	0.000201	0.000236	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HTR1A—Parkinson's disease	0.000201	0.000236	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CYCS—Parkinson's disease	0.000198	0.000233	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TAC1—Parkinson's disease	0.000198	0.000232	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000197	0.000232	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—DRD1—Parkinson's disease	0.000194	0.000228	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000194	0.000228	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FGF20—Parkinson's disease	0.000194	0.000228	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—INSR—Parkinson's disease	0.00019	0.000223	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYP2D6—Parkinson's disease	0.000188	0.000221	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000188	0.000221	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—DRD3—Parkinson's disease	0.000188	0.000221	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000188	0.00022	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—EDN1—Parkinson's disease	0.000187	0.00022	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	0.000187	0.000219	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CTGF—Parkinson's disease	0.000185	0.000217	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—DRD2—Parkinson's disease	0.000182	0.000214	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HTR7—Parkinson's disease	0.000182	0.000214	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00018	0.000212	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FGB—Parkinson's disease	0.00018	0.000211	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000179	0.000211	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	0.000179	0.00021	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	0.000176	0.000207	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TAC1—Parkinson's disease	0.000176	0.000207	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000176	0.000207	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—COMT—Parkinson's disease	0.000176	0.000206	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	0.000175	0.000206	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ADRBK1—Parkinson's disease	0.000175	0.000206	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GSTP1—Parkinson's disease	0.000175	0.000205	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—MAOA—Parkinson's disease	0.000174	0.000205	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	0.000173	0.000204	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	0.000173	0.000203	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—DRD1—Parkinson's disease	0.000173	0.000203	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—HMOX1—Parkinson's disease	0.000172	0.000203	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	0.000172	0.000202	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—INS—Parkinson's disease	0.000172	0.000202	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—NQO1—Parkinson's disease	0.00017	0.0002	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—DRD2—Parkinson's disease	0.00017	0.000199	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HTR7—Parkinson's disease	0.00017	0.000199	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	0.000169	0.000199	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—TH—Parkinson's disease	0.000168	0.000197	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—DRD3—Parkinson's disease	0.000167	0.000197	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ABCB1—Parkinson's disease	0.000165	0.000194	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	0.000164	0.000193	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	0.000164	0.000193	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000163	0.000192	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	0.000163	0.000192	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYCS—Parkinson's disease	0.000161	0.000189	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GSTM1—Parkinson's disease	0.000161	0.000189	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	0.00016	0.000189	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	0.000157	0.000185	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000156	0.000183	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GPX1—Parkinson's disease	0.000154	0.000181	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000153	0.00018	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	0.000152	0.000179	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	0.000152	0.000179	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—DRD2—Parkinson's disease	0.000151	0.000178	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HTR7—Parkinson's disease	0.000151	0.000178	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	0.000148	0.000174	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	0.000148	0.000174	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	0.000147	0.000173	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	0.000145	0.000171	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—COMT—Parkinson's disease	0.000143	0.000168	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000142	0.000167	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	0.000142	0.000167	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GSTP1—Parkinson's disease	0.000142	0.000167	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—MTHFR—Parkinson's disease	0.000142	0.000167	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—MAOA—Parkinson's disease	0.000142	0.000166	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—HMOX1—Parkinson's disease	0.00014	0.000165	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	0.000138	0.000162	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	0.000138	0.000162	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	0.000137	0.000162	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	0.000136	0.00016	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ABCB1—Parkinson's disease	0.000134	0.000158	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	0.000134	0.000157	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—APOE—Parkinson's disease	0.000132	0.000155	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GSTM1—Parkinson's disease	0.00013	0.000153	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CASP3—Parkinson's disease	0.000128	0.00015	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	0.000127	0.00015	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—IL6—Parkinson's disease	0.000127	0.000149	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IGF2—Parkinson's disease	0.000127	0.000149	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GPX1—Parkinson's disease	0.000125	0.000147	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	0.000125	0.000147	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	0.000124	0.000146	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	0.000122	0.000144	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EDN1—Parkinson's disease	0.000121	0.000142	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	0.00012	0.000141	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	0.000119	0.00014	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	0.000119	0.00014	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	0.000118	0.000139	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MAPK8—Parkinson's disease	0.000118	0.000138	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	0.000116	0.000136	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—MTHFR—Parkinson's disease	0.000115	0.000136	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—INS—Parkinson's disease	0.000113	0.000133	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	0.000112	0.000131	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NGF—Parkinson's disease	0.000111	0.000131	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	0.00011	0.00013	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	0.00011	0.00013	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	0.000109	0.000128	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—APOE—Parkinson's disease	0.000107	0.000126	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	0.000106	0.000124	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	0.000104	0.000122	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	0.000101	0.000119	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—INS—Parkinson's disease	0.000101	0.000119	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APOE—Parkinson's disease	9.84e-05	0.000116	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	9.66e-05	0.000114	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	9.65e-05	0.000113	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—INS—Parkinson's disease	9.44e-05	0.000111	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—INS—Parkinson's disease	9.17e-05	0.000108	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	8.97e-05	0.000105	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—INS—Parkinson's disease	8.41e-05	9.89e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—INS—Parkinson's disease	8.25e-05	9.7e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—INS—Parkinson's disease	7.67e-05	9.01e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	7.52e-05	8.84e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL6—Parkinson's disease	7.51e-05	8.83e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	7.47e-05	8.79e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	7.03e-05	8.26e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	6.98e-05	8.21e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	6.91e-05	8.13e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	6.46e-05	7.59e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CASP3—Parkinson's disease	6.26e-05	7.36e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL6—Parkinson's disease	6.22e-05	7.31e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	6.14e-05	7.22e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	6.1e-05	7.17e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	5.75e-05	6.76e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	5.71e-05	6.71e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	5.67e-05	6.67e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	5.65e-05	6.64e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	5.25e-05	6.17e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	4.42e-05	5.19e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	4.12e-05	4.85e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL6—Parkinson's disease	3.67e-05	4.32e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	3.61e-05	4.24e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	3.35e-05	3.94e-05	CbGpPWpGaD
